News & Updates
Stay up to date with the latest developments in rare disease research, platform updates, and community milestones.
SHRARE Launches the World's First Sharing-Economy Platform for Pharma Innovation
Led by Co-Founder and CTO Francesco Cavalli, SHRARE introduces an AI-powered marketplace that connects researchers, transforms raw clinical work into Medical Product Candidates (MPCs), and partners with pharma to reshape drug discovery.
Read MoreBuilding a Strategic IP Portfolio
SHRARE has filed its first patent applications, strengthening its intellectual property base and protecting the AI-driven transformation of research into licensable therapies.
Read MoreExpansion to the United States
We are opening an operating company in the U.S. (New York or California) to accelerate collaborations with top universities, pharma partners, and investors.
Read MoreBecoming a Public Benefit Corporation (PBC)
SHRARE USA is transforming into a Public Benefit Corporation, legally committing to balancing profit with patient impact.
Read MoreScaling Operations for Growth
With the first version of the AI Marketplace live, SHRARE is investing in infrastructure and processes to ensure global scalability.
Read MoreA Collective Leadership Model
Inspired by ON Holding, SHRARE is building a CEO team of complementary expertise. Gianpaolo Turri joins as COO & Co-CEO, while Pierre A. Morgon becomes Chief Business Officer.
Read More